The Center for Genetics and Society brings social justice and human rights to the center of public and policy discussions about human genetics and assisted reproduction.

Featured

The Global Economy of Human Eggs: An interview with Diane Tober

By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors | 03.25.2026
Biopolitical Times

A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
 

Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...

Other Countries

Surrogacy goes more mainstream

By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026

Aggregated News

More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.

Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...

U.S. Federal

Public Health, Vaccines and Modern Eugenics

By Pete Shanks | 02.27.2026
Biopolitical Times

Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The...

Bioethics

Eugenics and the Modern Synthesis, Part II

By Jessica Riskin, Los Ángeles Review of Books | 03.24.2026

Aggregated News

 

This is the second part of the 14th installment in the Legacies of Eugenics series, which features essays by...

Bioethics

Biopolitical Times

Serial Entrepreneur and “Frankenstein’s” Ex Launches (Another) New Germline Editing Startup

By Pete Shanks | 03.26.2026

Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others...

Policies

The Global Economy of Human Eggs: An interview with Diane Tober

By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors | 03.25.2026

A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on...

Other Countries

Public Health, Vaccines and Modern Eugenics

By Pete Shanks | 02.27.2026

Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The...

Bioethics

News

Surrogacy goes more mainstream

By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026

More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.

Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...

U.S. Federal

Surrogacy laws are all over the map

By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026

Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/

Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...

Policies

California-Financed Gene Therapy Scores Historic First Commercial Approval

By David Jensen, The California Stem Cell Report | 03.26.2026

SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...

Genomics

Eugenics and the Modern Synthesis, Part II

By Jessica Riskin, Los Ángeles Review of Books | 03.24.2026

 

This is the second part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the...

Bioethics

Video
Reproduction and Family Formation: The State and the Market
Use Gene Editing to Make Better Babies | Debate | Intelligence Squared U.S.
The 'Perfect' Baby?: The Dangers of Gene Editing in Assisted Reproduction